info@synchemia.com | sales@synchemia.com 
9766925136 
N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014467 |
| CAS No | NA |
| Mol.F. | C19H18FN5O4 |
| Mol.Wt. | 399.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014469 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014470 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014471 |
| CAS No | NA |
| Mol.F. | C28H34ClN7O5S |
| Mol.Wt. | 616.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014472 |
| CAS No | NA |
| Mol.F. | C27H27N3O8 |
| Mol.Wt. | 521.5 |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-N014473 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O |
| Mol.Wt. | 348.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014474 |
| CAS No | 1053740-92-3 |
| Mol.F. | C22H30N4O6 |
| Mol.Wt. | 446.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014475 |
| CAS No | NA |
| Mol.F. | C28H35ClN6O4S |
| Mol.Wt. | 587.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014476 |
| CAS No | NA |
| Mol.F. | C13H10ClN3O3 |
| Mol.Wt. | 291.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014477 |
| CAS No | NA |
| Mol.F. | C21H22Cl2N2O7 |
| Mol.Wt. | 485.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
.png)
| CAT No | SRC-N014478 |
| CAS No | NA |
| Mol.F. | C26H26N2O5 |
| Mol.Wt. | 446.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014479 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014480 |
| CAS No | NA |
| Mol.F. | C21H20F3IN4O3 |
| Mol.Wt. | 560.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014481 |
| CAS No | NA |
| Mol.F. | C21H19F3IN5O4 |
| Mol.Wt. | 589.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014482 |
| CAS No | NA |
| Mol.F. | C21H21Cl2FN6O2 |
| Mol.Wt. | 479.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014483 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |
